$GNCA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOCEA BIOSCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENOCEA BIOSCIENCES, INC.. Get notifications about new insider transactions in GENOCEA BIOSCIENCES, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Option Exercise | A | 3.01 | 112,500 | 338,625 | 112,500 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Grant | A | 0.00 | 37,500 | 0 | 37,500 | 0 to 37.5 K |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | A | 0.00 | 600,000 | 0 | 600,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | A | 3.01 | 450,000 | 1,354,500 | 450,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Grant | A | 0.00 | 150,000 | 0 | 150,000 | 0 to 150 K |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | Chief Scientific Of ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | Chief Scientific Of ... | Option Exercise | A | 3.01 | 131,250 | 395,063 | 131,250 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | Chief Scientific Of ... | Grant | A | 0.00 | 43,750 | 0 | 43,750 | 0 to 43.8 K |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Option Exercise | A | 3.01 | 93,750 | 282,188 | 93,750 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Option Exercise | A | 3.01 | 93,750 | 282,188 | 93,750 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Grant | A | 0.00 | 31,250 | 0 | 31,250 | 0 to 31.3 K |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Grant | A | 0.00 | 31,250 | 0 | 31,250 | 0 to 31.3 K |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 3.01 | 93,750 | 282,188 | 93,750 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 3.01 | 93,750 | 282,188 | 93,750 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Grant | A | 0.00 | 31,250 | 0 | 31,250 | 0 to 31.3 K |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Grant | A | 0.00 | 31,250 | 0 | 31,250 | 0 to 31.3 K |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | SUMER JACQUELYN L | CHIEF LEGAL & COMPL ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | SUMER JACQUELYN L | CHIEF LEGAL & COMPL ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | STAPLETON RAYMOND D JR | EVP PHARM SCI & MFG | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | STAPLETON RAYMOND D JR | EVP PHARM SCI & MFG | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 02 2021 | GNCA | GENOCEA BIOSCIENCE ... | SUMER JACQUELYN L | CHIEF LEGAL & COMPL ... | Option Exercise | A | 3.07 | 115,000 | 353,050 | 115,000 | |
Feb 18 2021 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | M | 1.66 | 16,500 | 27,390 | 171,000 | |
Feb 18 2021 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | M | 2.72 | 19,998 | 54,395 | 86,690 | |
Feb 18 2021 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Buy | M | 2.72 | 19,998 | 54,395 | 63,750 | 43.8 K to 63.8 K (+45.71 %) |
Feb 18 2021 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Buy | M | 1.66 | 16,500 | 27,390 | 43,752 | 27.3 K to 43.8 K (+60.55 %) |
Feb 01 2021 | GNCA | GENOCEA BIOSCIENCE ... | STAPLETON RAYMOND D JR | EVP PHARM SCI & MFG | Option Exercise | A | 2.99 | 125,000 | 373,750 | 125,000 | |
Nov 10 2020 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Buy | P | 2.06 | 4,760 | 9,806 | 4,760 | 0 to 4.8 K |
Jul 30 2020 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | P | 2.25 | 1,260,504 | 2,836,134 | 1,260,504 | |
Jul 30 2020 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 2.25 | 1,260,504 | 2,836,134 | 4,626,389 | 3.4 M to 4.6 M (+37.45 %) |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | Walker Paul Edward | 10% Owner | Option Exercise | P | 2.25 | 3,151,260 | 7,090,335 | 3,151,260 | |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | Walker Paul Edward | 10% Owner | Buy | P | 2.25 | 3,151,260 | 7,090,335 | 10,376,936 | 7.2 M to 10.4 M (+43.61 %) |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | Sonsini Peter W. | 10% Owner | Option Exercise | P | 2.25 | 3,151,260 | 7,090,335 | 3,151,260 | |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | Sonsini Peter W. | 10% Owner | Buy | P | 2.25 | 3,151,260 | 7,090,335 | 10,376,936 | 7.2 M to 10.4 M (+43.61 %) |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 2.25 | 3,151,260 | 7,090,335 | 3,151,260 | |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.25 | 3,151,260 | 7,090,335 | 10,376,936 | 7.2 M to 10.4 M (+43.61 %) |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | MAKOWER JOSHUA | 10% Owner | Option Exercise | P | 2.25 | 3,151,260 | 7,090,335 | 3,151,260 | |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | MAKOWER JOSHUA | 10% Owner | Buy | P | 2.25 | 3,151,260 | 7,090,335 | 10,376,936 | 7.2 M to 10.4 M (+43.61 %) |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | Makhzoumi Mohamad | 10% Owner | Option Exercise | P | 2.25 | 3,151,260 | 7,090,335 | 3,151,260 | |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | Makhzoumi Mohamad | 10% Owner | Buy | P | 2.25 | 3,151,260 | 7,090,335 | 10,376,936 | 7.2 M to 10.4 M (+43.61 %) |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | Florence Anthony A. Jr. | 10% Owner | Option Exercise | P | 2.25 | 3,151,260 | 7,090,335 | 3,151,260 | |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 2.25 | 3,151,260 | 7,090,335 | 10,376,936 | 7.2 M to 10.4 M (+43.61 %) |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | Chang Carmen | 10% Owner | Option Exercise | P | 2.25 | 3,151,260 | 7,090,335 | 3,151,260 | |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | Chang Carmen | 10% Owner | Buy | P | 2.25 | 3,151,260 | 7,090,335 | 10,376,936 | 7.2 M to 10.4 M (+43.61 %) |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Option Exercise | P | 2.25 | 3,151,260 | 7,090,335 | 3,151,260 | |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Buy | P | 2.25 | 3,151,260 | 7,090,335 | 10,376,936 | 7.2 M to 10.4 M (+43.61 %) |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | BASKETT FOREST | 10% Owner | Option Exercise | P | 2.25 | 3,151,260 | 7,090,335 | 3,151,260 | |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | BASKETT FOREST | 10% Owner | Buy | P | 2.25 | 3,151,260 | 7,090,335 | 10,376,936 | 7.2 M to 10.4 M (+43.61 %) |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | New Enterprise Associates 16, ... | 10% Owner | Option Exercise | P | 2.25 | 3,151,260 | 7,090,335 | 3,151,260 | |
Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | New Enterprise Associates 16, ... | 10% Owner | Buy | P | 2.25 | 3,151,260 | 7,090,335 | 10,376,936 | 7.2 M to 10.4 M (+43.61 %) |
Jun 19 2020 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
Jun 19 2020 | GNCA | GENOCEA BIOSCIENCE ... | Mayer Howard | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
Jun 19 2020 | GNCA | GENOCEA BIOSCIENCE ... | BATE KENNETH | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
Jun 19 2020 | GNCA | GENOCEA BIOSCIENCE ... | Higgins Michael J | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
Jun 19 2020 | GNCA | GENOCEA BIOSCIENCE ... | Cooper Ronald Harold Wilfred | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
Jun 19 2020 | GNCA | GENOCEA BIOSCIENCE ... | Bosley Katrine | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | Chief Scientific Of ... | Option Exercise | A | 2.72 | 31,500 | 85,680 | 31,500 | |
Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | Chief Scientific Of ... | Grant | A | 0.00 | 8,365 | 0 | 8,365 | 0 to 8.4 K |
Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 2.72 | 24,938 | 67,831 | 24,938 | |
Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Grant | A | 0.00 | 6,623 | 0 | 6,623 | 0 to 6.6 K |
Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Singh Narinderjeet | SENIOR VP, PS&M | Option Exercise | A | 2.72 | 31,500 | 85,680 | 31,500 | |
Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Singh Narinderjeet | SENIOR VP, PS&M | Grant | A | 0.00 | 8,365 | 0 | 8,365 | 0 to 8.4 K |
Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.72 | 24,938 | 67,831 | 24,938 | |
Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Grant | A | 0.00 | 6,623 | 0 | 6,623 | 0 to 6.6 K |
Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | A | 2.72 | 106,688 | 290,191 | 106,688 | |
Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Grant | A | 0.00 | 27,344 | 0 | 27,344 | 0 to 27.3 K |
Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Option Exercise | A | 2.72 | 24,938 | 67,831 | 24,938 | |
Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Grant | A | 0.00 | 6,623 | 0 | 6,623 | 0 to 6.6 K |
Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | A | 1.66 | 187,500 | 311,250 | 187,500 | |
Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Grant | A | 0.00 | 50,783 | 0 | 50,783 | 0 to 50.8 K |
Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Singh Narinderjeet | SENIOR VP, PS&M | Option Exercise | A | 1.66 | 58,500 | 97,110 | 58,500 | |
Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Singh Narinderjeet | SENIOR VP, PS&M | Grant | A | 0.00 | 15,536 | 0 | 15,536 | 0 to 15.5 K |
Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 1.66 | 46,313 | 76,880 | 46,313 | |
Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Grant | A | 0.00 | 12,299 | 0 | 12,299 | 0 to 12.3 K |
Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | Chief Scientific Of ... | Option Exercise | A | 1.66 | 58,500 | 97,110 | 58,500 | |
Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | Chief Scientific Of ... | Grant | A | 0.00 | 15,536 | 0 | 15,536 | 0 to 15.5 K |
Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Option Exercise | A | 1.66 | 46,313 | 76,880 | 46,313 | |
Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Grant | A | 0.00 | 12,299 | 0 | 12,299 | 0 to 12.3 K |
Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Option Exercise | A | 1.66 | 46,313 | 76,880 | 46,313 | |
Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Grant | A | 0.00 | 12,299 | 0 | 12,299 | 0 to 12.3 K |
Feb 18 2020 | GNCA | GENOCEA BIOSCIENCE ... | Schwab Gisela | Director | Option Exercise | A | 2.10 | 9,375 | 19,688 | 9,375 | |
Feb 18 2020 | GNCA | GENOCEA BIOSCIENCE ... | Schwab Gisela | Director | Option Exercise | A | 2.10 | 9,375 | 19,688 | 9,375 | |
Jul 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Option Exercise | A | 3.66 | 5,625 | 20,588 | 5,625 | |
Jul 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Mayer Howard | Director | Option Exercise | A | 3.66 | 5,625 | 20,588 | 5,625 | |
Jul 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Siber George | Director | Option Exercise | A | 3.66 | 5,625 | 20,588 | 5,625 | |
Jul 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Higgins Michael J | Director | Option Exercise | A | 3.66 | 5,625 | 20,588 | 5,625 | |
Jul 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Cooper Ronald Harold Wilfred | Director | Option Exercise | A | 3.66 | 5,625 | 20,588 | 5,625 | |
Jul 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Bosley Katrine | Director | Option Exercise | A | 3.66 | 5,625 | 20,588 | 5,625 | |
Jul 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | BATE KENNETH | Director | Option Exercise | A | 3.66 | 5,625 | 20,588 | 5,625 | |
Jun 26 2019 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 3.50 | 1,857,142 | 6,499,997 | 3,365,884 | 1.5 M to 3.4 M (+123.09 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | Sonsini Peter W. | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | SANDELL SCOTT D | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | Sonsini Peter W. | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | SANDELL SCOTT D | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | MOTT DAVID M | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | MOTT DAVID M | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | MAKOWER JOSHUA | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | Makhzoumi Mohamad | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | MAKOWER JOSHUA | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | Makhzoumi Mohamad | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | Chang Carmen | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | Chang Carmen | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | BASKETT FOREST | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | BARRIS PETER J | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | New Enterprise Associates 16, ... | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | BASKETT FOREST | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | BARRIS PETER J | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | New Enterprise Associates 16, ... | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
May 09 2019 | GNCA | GENOCEA BIOSCIENCE ... | Singh Narinderjeet | SENIOR VP, PS&M | Option Exercise | M | 0.54 | 7,291 | 3,937 | 328,127 | |
May 09 2019 | GNCA | GENOCEA BIOSCIENCE ... | Singh Narinderjeet | SENIOR VP, PS&M | Buy | M | 0.54 | 7,291 | 3,937 | 61,873 | 54.6 K to 61.9 K (+13.36 %) |
Apr 12 2019 | GNCA | GENOCEA BIOSCIENCE ... | Singh Narinderjeet | SENIOR VP, PS&M | Option Exercise | M | 0.54 | 7,291 | 3,937 | 335,418 | |
Apr 12 2019 | GNCA | GENOCEA BIOSCIENCE ... | Singh Narinderjeet | SENIOR VP, PS&M | Buy | M | 0.54 | 7,291 | 3,937 | 54,582 | 47.3 K to 54.6 K (+15.42 %) |
Mar 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Singh Narinderjeet | SENIOR VP, PS&M | Option Exercise | M | 0.54 | 7,291 | 3,937 | 342,709 | |
Mar 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Singh Narinderjeet | SENIOR VP, PS&M | Buy | M | 0.54 | 7,291 | 3,937 | 47,291 | 40 K to 47.3 K (+18.23 %) |
Mar 18 2019 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | M | 0.54 | 15,000 | 8,100 | 735,000 | |
Mar 18 2019 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Buy | M | 0.54 | 15,000 | 8,100 | 119,931 | 104.9 K to 119.9 K (+14.30 %) |
Mar 07 2019 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.83 | 475,000 | 394,250 | 475,000 | |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Sonsini Peter W. | 10% Owner | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Sonsini Peter W. | 10% Owner | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | SANDELL SCOTT D | 10% Owner | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Chang Carmen | 10% Owner | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Chang Carmen | 10% Owner | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | BASKETT FOREST | 10% Owner | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | BASKETT FOREST | 10% Owner | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | BARRIS PETER J | 10% Owner | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | BARRIS PETER J | 10% Owner | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | New Enterprise Associates 16, ... | 10% Owner | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | New Enterprise Associates 16, ... | 10% Owner | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Singh Narinderjeet | SENIOR VP, PS&M | Option Exercise | A | 0.54 | 350,000 | 189,000 | 350,000 | |
Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | A | 0.54 | 750,000 | 405,000 | 750,000 | |
Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 0.54 | 300,000 | 162,000 | 300,000 | |
Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Option Exercise | A | 0.54 | 300,000 | 162,000 | 300,000 | |
Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Alfieri Michael | Principle Financial ... | Option Exercise | A | 0.54 | 75,000 | 40,500 | 75,000 | |
Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Meisner Derek M | SENIOR VP AND GENER ... | Option Exercise | A | 0.54 | 200,000 | 108,000 | 200,000 | |
Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | Chief Scientific Of ... | Option Exercise | A | 0.54 | 350,000 | 189,000 | 350,000 | |
Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Carroll Pamela | SVP IMMUNO-ONCOLOGY | Option Exercise | A | 0.54 | 200,000 | 108,000 | 200,000 | |
Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Singh Narinderjeet | SENIOR VP, PS&M | Option Exercise | A | 0.54 | 350,000 | 189,000 | 350,000 | |
Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | A | 0.54 | 750,000 | 405,000 | 750,000 | |
Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 0.54 | 300,000 | 162,000 | 300,000 |